News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Finance
South San Francisco's Veracyte, Inc. (VCYT) Brings In $40 Million 4/23/2015
Jounce Infused With $56 Million to Develop Cancer Immunotherapy Programs 4/23/2015
Buy Vertex (VRTX) Now for $45B Or Risk It All, Analyst Tells Gilead (GILD) 4/22/2015
Stealth SoCal Startup Metacrine Eyes $33 Million and Talent-Cash From Seragon Alums? 4/22/2015
New York VC Firm Oberland Capital Secures $425 Million for Life Sciences, Medtech 4/22/2015
SciFluor Life Sciences, LLC Locks In $30 Million and Taps Ex-Neurogen Corporation (NRGN) CEO as Chairman 4/22/2015
Cambridge's Dimension Therapeutics Nabs $65 Million 4/21/2015
Brandon Capital Partners Dedicates $200 Million to Seeking the Next Big Thing 4/20/2015
Boston VC Firm Atlas Venture Set Sights on Biotech Startups With $280 Million Fund and New Home 4/17/2015
Medican Enterprises Extends Closing On Two Phoenix Area Properties 4/17/2015
This San Francisco Startup Wants to be the Salesforce of Biotech 4/16/2015
Life Science Start-Ups Salivate, As NEA Announces Record-Setting $3.1B Funds 4/16/2015
Biologics, Inc. (NC) Secures Over $29 Million In Copay Assistance For Cancer Patients In 2014 4/15/2015
Ascenion GmbH's Portfolio Company OMEICOS Therapeutics Raises EUR 6.2 Million In Series A To Advance Lead Candidate In Atrial Fibrillation 4/15/2015
StemBioSys Closes $8 Million Series A Financing 4/14/2015
Castle Biosciences Secures $6 Million Credit Facility From Silicon Valley Bank 4/14/2015
Innocrin Pharmaceuticals Raises $28 Million in Series D Financing 4/14/2015
Clyde Biosciences, A Leading Drug Toxicity Testing Company, Closes Series A Investment 4/14/2015
Voyager Therapeutics Snags $60 Million With "Crossover" Investors as Analysts Predict an IPO 4/13/2015
Fidelity CEO Uses Personal Fortune to Bet on Cancer Related IPOs Like Coherus, Adaptimmune and Blueprint Medicines 4/13/2015
Angionetics Initial Equity Funding To Advance As Independent Company To Develop And Commercialize Phase 3 Generx Gene Therapy Product Candidate 4/13/2015
Oxford Finance Closes $20 Million Debt Facility With Inhibrx 4/10/2015
Belgian Start-Up UgenTec Receives Funding From European Investors 4/10/2015
Matinas BioPharma Completes Private Placement Of $10 Million 4/10/2015
Embera NeuroTherapeutics, Inc. Secures A-2 Financing To Advance EMB-001 For Addictions Through Phase 1 Clinical Trial 4/10/2015
Edge Therapeutics Banks $72.5 Million for Phase III Brain Hemorrhage Study 4/9/2015
Silence Therapeutics Scrounges Up $58 Million to Expand RNA Research 4/9/2015
Ark Biosciences Of Shanghai Completes Series A Funding 4/8/2015
Raising $10M in Series A, Alzheon CEO Bets He Can Beat Biogen (BIIB) With World's First Alzheimer's Drug 4/8/2015
Nabriva Raises $120 Million, Headed to Phase III for New Antibiotic 4/7/2015
True North Therapeutics CEO Delivers With $35 Million to Take Lead Candidate Into Clinical Trial 4/7/2015
Gilead (GILD) and Amgen (AMGN) Hand Out Dividends; Other Biotechs Feel the Heat So Who's Next? 4/7/2015
National MS Society Invests $28 Million In New Research To Stop Multiple Sclerosis, Restore Function And End MS Forever 4/7/2015
MicroBiome Therapeutics LLC Reports Advances In Three Microbiome Modulator Programs As It Launches Series B Financing 4/7/2015
CeraPedics, Inc. Announces Closing Of Loan And Equity Financing 4/7/2015
Cellular Biomedicine Group (CBMG) Announces Closing Of $19.6 Million Private Placement Offering 4/7/2015
PhoreMost Ltd Founded To Identify New Druggable Targets For Therapeutics 4/7/2015
MicroBiome Therapeutics LLC Reports Advances In Three Microbiome Modulator Programs As It Launches Series B Financing 4/7/2015
Euclises Pharmaceuticals Completes Financing Round 4/7/2015
Neuronascent Secures Financing For Development Of Its Alzheimer's Therapeutic 4/7/2015
Quebec Breast Cancer Foundation Release: Breast Cancer: $4.5 Million For Nine Homegrown Researchers 4/7/2015
Bay Area's Lux Capital Banks $350 Million to Back Daring Life Science Entrepreneurs With a Futuristic Vision 4/6/2015
Taubman Institute Receives $3 Million Wexner Gift To Support Emerging Physician-Researchers 4/6/2015
MabVax Therapeutics, Inc. Announces Closing Of Financing 4/6/2015
Northwest Biotherapeutics (NWBO) Announces $40 Million Financing 4/2/2015
Caribou Biosciences Raises $11 Million In Series A Funding 4/2/2015
aTyr Pharma $76 Million Series E Gets IPO Rumors Flying 4/2/2015
Thrasos Scores $21M to Complete Phase II THR-184, Expands Renal Portfolio 4/1/2015
Alzheimer's Drug Discovery Foundation Funds Signum Biosciences to Move Novel Therapeutics Towards Clinic 3/31/2015
Tiziana Life Sciences Plc Placing To Raise £2.55 Million 3/31/2015
Algal Scientific Secures $7 Million In Funding To Accelerate Its Efforts To Transform The World’s Food Supply 3/31/2015
Cynapsus Therapeutics (CYNAF) Announces CAD$21 Million Private Placement 3/31/2015
Novan Therapeutics Secures $50 Million Private Financing; Funds Intended to Advance SB204 into Phase 3 3/30/2015
Alzheimer's Disease Research And The Ellison Foundation: Investing $6 Million In A Precision Medicine Approach At UW Medicine 3/30/2015
ImmunoGen (IMGN) Announces $200 Million Non-Dilutive Royalty Transaction 3/30/2015
CoreRx Grabs $7M for Expansion, Plans to Increase Staff By 40% 3/27/2015
Ex-Teva (TEVA) CEO Levin Finds New Home at Neuro Startup Ovid Therapeutics, As It Raises $5M 3/27/2015
Gelesis Closes $22M Equity Financing 3/26/2015
Redx Pharma To Raise £15 Million On Stock Market Debut 3/26/2015
Repositive Ltd Raises £300k Seed Funding To Launch Genomic Data Discovery Platform 3/26/2015
Early-Stage Biotech Star Flagship Ventures Scores $537M for New Fund 3/26/2015
Gelesis Reels in $22M More, Increases Clinical Trials for Gelesis100 3/26/2015
BioPharm Executive: Why Your Last Investment Blew Up 3/26/2015
Horizon Discovery Group plc And Partners Awarded Up To £6.2 Million Funding Under Advanced Manufacturing Supply Chain Initiative 3/25/2015
FLAG Therapeutics Awarded A North Carolina Biotechnology Center Small Business Research Loan To Advance Its Lead Oncology Drug 3/25/2015
Led By Ex-Elan (ELN) Execs, Malin Rakes in $350 Million and Looks to Invest in Viamet, Novan Therapeutics 3/25/2015
Boston Startup Semma Therapeutics Reels in $44 Million; In Process of Hiring and Leasing Lab Space 3/25/2015
Rigontec GmbH Raises €4.8 Million In A Second Closing Of Its Series A Financing 3/24/2015
Eli Lilly (LLY),Novartis AG (NVS)-Backed Startup, Aeglea, Nabs $44 Million 3/23/2015
Nymox Pharmaceutical (NYMX) Announces Private Placements Of $400,000 3/23/2015
Joined Polish Investment Fund Management Release: Poland’s First Institutional Venture Capital Fund Dedicated To Life Science Announces First Closing At $ 42 Million 3/23/2015
Anthera, Inc. Announces $3 Million Research Award From Cystic Fibrosis Foundation Therapeutics, Inc. For Development Of Sollpura - A Novel Enzyme Therapy 3/20/2015
Minerva Neurosciences, Inc. (NERV) Completes Private Placement, Raises $31 Million 3/19/2015
MA Life Science Growing: Backed By Eli Lilly (LLY) and Pfizer (PFE), Nimbus Therapeutics Bankrolls $43 Million 3/18/2015
Epizyme (EPZM) Announces Pricing Of Public Offering Of Common Stock 3/18/2015
Johnson & Johnson (JNJ) Announces Strategic Investment Alliance To Combat Dementia Globally 3/17/2015
NanoTherapies Closes Final Round Of Financing For Completion Of New Advanced Development And Manufacturing Facility 3/17/2015
Epizyme (EPZM) Eyes $100 Million for Mid-Stage Trials of a Reacquired Drug 3/17/2015
Big Name VCs Dump $80 Million Into Bay Area Startup Allergen Research 3/13/2015
Led By a Serial Biotech Entrepreneur, Kura Oncology Forges Pact With Johnson & Johnson (JNJ) Unit and Bags $60 Million to Work on Shelved Drug 3/13/2015
Depomed, Inc. (DEPO) Nabs $575 Million Debt Facility From Deerfield, Pharmakon Advisors 3/13/2015
Minerva Neurosciences, Inc. (NERV) Announces $31 Million Financing 3/13/2015
AstraZeneca PLC (AZN)-Backed PhaseBio Locks in $40 Million 3/12/2015
Champions Oncology, Inc. (CSBR) Announces $14 Million Capital Raise 3/12/2015
Inflection Biosciences Raises €725,000 In Second Financing Round 3/11/2015
AmpliPhi Biosciences Corporation (APHB) Announces $13 Million Financing 3/11/2015
BioLineRx Ltd. Closes $28.75 Million Underwritten Public Offering Of Its American Depositary Shares 3/11/2015
Seven Bridges Genomics UK To Receive £1.95 Million To Launch Graph Genome 3/11/2015
AEterna Zentaris (AEZS) Announces Closing Of US$37 Million Public Offering Of Common Shares And Warrants 3/11/2015
Collegium Scores $50 Million to Advance Abuse-Deterrent Opioid 3/10/2015
TapImmune Inc. (TPIV) Receives $1,000,000 From Strategic Investor 3/10/2015
GrayBug Raises $1.74 Million In Series A2 Financing 3/10/2015
Ophthotech Corporation (OPHT) Achieves Second $50 Million Enrollment Milestone Under Ex-US Licensing And Commercial Agreement With Novartis Pharma AG (NVS) For Fovista 3/10/2015
Bill & Melinda Gates Foundation Injects $52 Million Into CureVac 3/9/2015
Tobira Therapeutics Inc. Closes Financing To Support Development Of CVC In Non-Alcoholic Steatohepatitis 3/9/2015
RegeneRx Biopharmaceuticals, Inc. (RGRX) Joint Venture Partner Receives $7.28 Million USD From Korean Government And Venture Fund For U.S. Development Of RGN-259/GBT-201 3/9/2015
Dyadic International, Inc. Raises $2 Million In Private Placement Of Convertible Note 3/9/2015
Addex Therapeutics (ADXN.SW) Raises CHF2.8 million In A Private Placement And Extends Cash Runway Through 2017 3/9/2015
Phico Therapeutics Receives Translation Award To Advance Its SASPject PT4 Aimed At Escherichia Coli And Klebsiella Pneumoniae Towards Clinical Trials 3/9/2015
BioScrip (BIOS) Raises $62.5 Million In Private Placement Of Convertible Preferred Stock And Announces Plan For $20 Million Rights Offering 3/9/2015
iBIO Institute’s PROPEL Startups Raise Over $30 Million In 2014, Total Capital Raised Surpasses $140 Million 3/6/2015
BioLineRx Ltd. Prices $25 Million Underwritten Public Offering Of Its American Depositary Shares 3/6/2015
Amarin (AMRN) Bags $52.8 Million in New Capital 3/6/2015
Backed By Investors Like Ex-Genzyme (GENZ) CEO, Aura Biosciences Locks In $21 Million 3/5/2015
Stanford University Spinout Alkahest Lands $37.5 Million Investment 3/5/2015
CAPNIA, Inc. Announces Receipt Of $3.6 Million From Series B Warrant Exercise And Issuance Of Series C Warrants 3/5/2015
Bayer HealthCare (BAY) Contributes $1 Million To Support Cancer Care Technology Platform 3/5/2015
With Two Ex-Elan (ELN) Execs at the Helm, Bay Area's Serenus Nabs $43 Million 3/4/2015
Bay Area's Tricida Scores $30 Million 3/4/2015
Massachusetts Startup Macrolide Pharma Launches With $22 Million in Pocket 3/4/2015
NovaBay Pharmaceuticals, Inc. (NBY) Announces $4.9 Million Private Placement 3/4/2015
Mersana Therapeutics Nabs $35 Million And A New CEO 3/3/2015
CALBIO15: Investors Will "Set Higher Bar" for Biotech IPOs in 2015 As Market Corrects, Says Panel 3/3/2015
Coronado Biosciences (CNDO) Closes $10 Million Private Placement Financing 3/3/2015
Chrono Therapeutics, Inc. Receives Investment From Rock Health To Advance Smartstoptm Smoking Cessation Technology 3/3/2015
Rheumatology Research Foundation Receives $1 Million Donation For Physician-Driven Medical Research 3/3/2015
BioGenerator Leads Investment In AgTech Company, Apse 3/3/2015
Vascular Pharmaceuticals Completes $9 Million Expansion Of Series A Financing 3/3/2015
Champions Oncology, Inc. (CSBR) Extends Convertible Debt Financing 3/2/2015
ImevaX Welcomes Kfw To Investor Syndicate In Second Closing Of Series A Financing 3/2/2015
Israeli Biotech Chiasma Reels in $70 Million Despite Roche (RHHBY) Pullout 2/27/2015
Gilead (GILD) Holds Cash Overseas to Save Billions on Taxes 2/27/2015
Illumina (ILMN) Accelerator Locks in $40 Million to Back Startups 2/26/2015
AMAG Pharmaceuticals, Inc. (AMAG) Prices Public Offering Of $175 Million Of Common Stock 2/26/2015
Spring Bank Pharmaceuticals, Inc. Completes $22 Million Financing 2/26/2015
Lyric Pharmaceuticals Announces $20.4M Series A Funding Round 2/26/2015
Life Sciences Ontario Release: Life Sciences In Ontario Contribute $38.5 Billion To Province's GDP 2/26/2015
Vectorious Medical Technologies Completes $5M Raise 2/26/2015
BioPharm Executive: Nine Ways to Avoid Investing in Biotech Duds 2/26/2015
PCORI Awards $64.1 Million To Support Five Pragmatic Clinical Studies 2/25/2015
Agile Therapeutics, Inc. Secures Debt Facility From Hercules Technology Growth Capital Of Up To $25 Million And Provides Update On Status Of Clinical Trial 2/25/2015
Eccrine Systems Raises $1.5 Million In Seed Funding 2/25/2015
GeoVax Labs Inc. (GOVX.OB) Announces Equity Financing Of Up To $6 Million 2/25/2015
Neos Therapeutics Completes $20.6 Million Financing To Further Advance Its Late-Stage ADHD Product Pipeline 2/25/2015
Vigilant Biosciences Closes $5.5 Million Series B Round Of Funding 2/24/2015
Calixar Raises €1 Million 2/24/2015
Prexton Therapeutics Raises €8.7 Million ($10 Million) In A Series A Round 2/24/2015
The Medicines Company (MDCO) Will See Dynamic 2015, As Trials, Approvals Gain: Citi 2/20/2015
3SBio Inc. (SSRX) Files for Hong Kong IPO; May Raise Up To $500 Million 2/20/2015
Cambridge Startup Pronutria Nabs $28.3 Million From Five Investors 2/19/2015
Agrimetis Completes A $7.3m Series A 2/19/2015
Novartis AG (NVS)-Backed Startup Merganser Biotech Reels in $28 Million 2/19/2015
Partikula Announces $5 Million Series A Funding To Develop Novel First-In-Class Mitochondrial Targeted Therapeutics 2/18/2015
Revamped Laguna Pharma Reels in $30 Million, Snags a New CEO, and Moves to San Diego 2/18/2015
Dance Biopharma Completes $9.5 Million Private Financing 2/18/2015
TraceLink, Inc. Secures $20 Million To Help Life Sciences Companies Protect Patients From Counterfeit Drugs 2/18/2015
Lineagen, Inc. Announces $19.8 Million Fundraising With Closing Of $15.8 Million Series C Round 2/18/2015
Advaxis, Inc. Completes $23 Million Financing 2/18/2015
IAVI Receives GSK Funding For The Human Vaccines Project To Accelerate Development Of Vaccines For Infectious Diseases And Cancer 2/17/2015
Enterprise Therapeutics Ltd Release: Drug Discovery Company Secures £1.6m ($2.4m) In Initial Series-A Financing From Epidarex Capital 2/17/2015
Bay Area Startup Unchained Labs Grabs $25 Million and Closes First Acquisition 2/13/2015
ACT Genomics Raises $8 Million In Its First Private Funding Round 2/13/2015
Skyepharma PLC (SKYEF) Announces Early Repayment Of The Remainder Of The CRC Finance Facility 2/13/2015
San Diego's Cidara Therapeutics Banks $42 Million Financing 2/12/2015
Cortendo Completes $26.4 Million In Private Placement From Leading U.S. And EU Investors 2/11/2015
NeuroVive Pharmaceutical AB: New Subsidiary Secures Funding Of Just Over USD 3 Million Ahead Of Potential IPO In Taiwan 2/11/2015
Peter Thiel's San Francisco Nonprofit Funds Three More Big Science Startups 2/11/2015
Pfizer (PFE) Commences $5 Billion Accelerated Share Repurchase 2/10/2015
Inoviem Scientific Raises €500,000 ($566,000) In Seed Funding From Cap Innov’Est 2/10/2015
GE Capital Agents $250 Million Financing For Amneal Pharmaceuticals 2/10/2015
Case Western Reserve University Awarded $3.9 Million for Innovative HIV Research 2/9/2015
TONIX Pharmaceuticals, Inc. (TNXP) Announces Closing Of $28.7 Million Public Offering Of Common Stock 2/9/2015
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) Locks In $30 Million 2/9/2015
Bio/Med Investor Network Release: Angel Network Formed To Invest In Early-Stage Life Science Companies 2/9/2015
Zedira Receives Further Funding To Develop Factor XIIIa-Blockers For Safe Anticogulation 2/9/2015
With the Help of Two Amgen (AMGN) Scientists, Ex-Dendreon (DNDN) CEO Launches Stealth Next-Gen Immunotherapy Startup in Seattle 2/9/2015
Tiny Startup G1 Therapeutics Grabs $33 Million to Compete With Big Pharma 2/6/2015
Mark Zuckerberg And Priscilla Chan Give $75 Million To Support San Francisco General Hospital And Trauma Center 2/6/2015
GlaxoSmithKline (GSK) Brings Three Banks on Board to Advise on Potential IPO 2/5/2015
GE Corporation (GE), Pfizer (PFE) Face $506 Billion Foreign-Cash Tax in Obama Plan 2/5/2015
Armetheon Closes $24 Million Series B Financing 2/5/2015
ORIG3N™ Closes $3.1 Million In Funding Lead By Hatteras Venture Partners 2/5/2015
Contextual Genomics And The Personalized Medicine Initiative Receive Funding From AstraZeneca PLC (AZN) For National Access Project For Cancer Testing 2/5/2015
Third Rock Ventures Launches $45 Million Bay Area Startup Revolution Medicines to Squeeze More Drugs From Nature 2/5/2015
Harvard University Professor Turned Biotech Master Banks $18 Million for Startup WaVe Lifesciences 2/4/2015
Backed By Eli Lilly (LLY), Roche (RHHBY), and Sanofi (SAN.PA), Startup Lysosomal Therapeutics Bags $20 Million 2/4/2015
American Heart Association Announces $4.6 Million Gift To Expand And Enhance Heart Attack Care In Rural Iowa 2/4/2015
Capricor Therapeutics, Inc. Announces $7 Million Private Placement Of Common Stock 2/4/2015
Cleveland Biolabs Inc. (CBLI) Announces $4.2 Million Financing 2/4/2015
The Eli Lilly (LLY) Foundation Commits $1 Million To Support AMPATH Oncology Institute In Kenya 2/4/2015
AuraSense Therapeutics Adds To Series C Financing 2/4/2015
Plagued By Multiple Facility Break-ins and Bad Management Decisions, Viropro Inc. (VPRO) Implements Restructuring Plan 2/3/2015
Dispersol Technologies Secures Over $10 Million With The Close Of Financing Led By Research Corporation Technologies 2/3/2015
Brickell Biotech Announces $10 Million Series C Financing To Fund Development Of Novel Dermatology Treatments 2/3/2015
Lilly Diabetes Donates $92,000 In Camp Scholarships To The American Diabetes Association 2/3/2015
OrbiMed Launches $924 Million Royalty & Credit Opportunities Fund 2/2/2015
SteadyMed Raises $12.2 Million In Equity Financing 1/29/2015
Medical Research Council Announced A £4.8 Million Investment 1/29/2015
InVivo Therapeutics Corporation (NVIV) Announces $12 Million Registered Direct Offering 1/29/2015
XenoPort, Inc. (XNPT) Announces Pricing Of $100 Million 2.50% Convertible Senior Notes Due 2022 1/29/2015
Exco InTouch Set For Further Growth And Expansion Into Healthcare Markets Through Recent £3.2 Million Investment Round 1/29/2015
Consort Medical Invests £2.2 Million In Atlas Genetics Series C Funding 1/29/2015
Pfizer (PFE)'s $33 Billion Cash Pile Has Everyone Speculating 1/28/2015
Vaccinogen Closes Second Tranche Of $80 Million Financing At $5.50 Per Unit 1/28/2015
BIONEXT Raises €1M In Seed Funding From The Cap Innov'Est Fund And Angel Investors 1/28/2015
Bill & Melinda Gates Foundation, UK Take Lead In $7.5 Billion Pledge For Children's Vaccines 1/28/2015
Vaccinogen Closes Second Tranche Of $80 Million Financing At $5.50 Per Unit 1/28/2015
ONCOLIX, INC. Announces Capital Raise Of $4.2 Million 1/27/2015
TxCell Receives EUR 1.7 Million From Bpifrance For Ovasave® Clinical Development In Refractory Crohn’s Disease 1/27/2015
THERAVECTYS Secures €1.9 Million From Bpifrance 1/26/2015



//-->